HopeStage
Back to all studies
RecruitingNCT06968390

Accelerated TMS for depression during pregnancy and after birth

About this titleRead the official source — NCT06968390
Device studyAges 18–55United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 55 years.

What will I do during this study?

Participants receive accelerated TMS (transcranial magnetic stimulation) over five consecutive days, with 10 stimulation sessions each day. The study includes pregnant and postpartum participants receiving treatment for depression.

Listed locations
BostonSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: August 5, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
24
Sponsor
Brigham and Women's Hospital
Sponsor type
Hospital / academic medical center
Study type
Device
Intervention type
DEVICE
Study phase
Not clearly listed
Locations
United States
Age range
From 18 Years to 55 Years
Official registry ID
NCT06968390
Official title
Show the full official title

Perinatal Accelerated iTBS Neuromodulation Therapy

Recruitment & locations

Recruiting

Boston

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Brigham and Women's Hospital, a hospital or academic medical center.

Who can participate?

Listed age limits: 18 years to 55 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies